Gencurix Past Earnings Performance
Past criteria checks 0/6
Gencurix's earnings have been declining at an average annual rate of -41.9%, while the Medical Equipment industry saw earnings growing at 16.2% annually. Revenues have been growing at an average rate of 6.1% per year.
Key information
-41.9%
Earnings growth rate
-34.6%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 6.1% |
| Return on equity | -141.8% |
| Net Margin | -564.6% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Gencurix makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2,897 | -16,357 | 8,378 | 4,379 |
| 31 Dec 23 | 2,600 | -19,260 | 8,173 | 4,529 |
| 30 Sep 23 | 2,700 | -19,437 | 8,292 | 4,769 |
| 30 Jun 23 | 2,222 | -20,466 | 8,199 | 4,750 |
| 31 Mar 23 | 2,212 | -24,239 | 7,935 | 4,734 |
| 31 Dec 22 | 2,559 | -24,597 | 7,662 | 4,181 |
| 30 Sep 22 | 3,492 | -30,828 | 7,492 | 3,827 |
| 30 Jun 22 | 3,700 | -34,361 | 6,958 | 3,782 |
| 31 Mar 22 | 3,464 | -17,475 | 6,000 | 3,597 |
| 31 Dec 21 | 3,047 | -34,670 | 5,845 | 3,475 |
| 30 Sep 21 | 2,133 | 10,751 | 5,340 | 3,715 |
| 30 Jun 21 | 1,678 | 19,815 | 5,061 | 3,502 |
| 31 Mar 21 | 1,801 | 12,320 | 4,833 | 3,378 |
| 31 Dec 20 | 1,572 | 33,108 | 4,640 | 3,154 |
| 30 Sep 20 | 816 | -7,335 | 4,192 | 2,892 |
| 31 Dec 19 | 137 | -9,162 | 3,928 | 1,811 |
Quality Earnings: A229000 is currently unprofitable.
Growing Profit Margin: A229000 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A229000 is unprofitable, and losses have increased over the past 5 years at a rate of 41.9% per year.
Accelerating Growth: Unable to compare A229000's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A229000 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4.1%).
Return on Equity
High ROE: A229000 has a negative Return on Equity (-141.77%), as it is currently unprofitable.